Find the latest myovant sciences ltd. (myov) stock quote, history, news and other vital information to help you with your stock trading and investing.
Periódico Metro (Reino Unido). Periódicos de Reino Unido
On average, they anticipate myovant sciences' stock price to reach $25.60 in the next twelve months.
Myov stock forecast zacks. The average price target is $26.00, with a high forecast of $32.00 and a low forecast of $18.00. Analysts expect that myovant sciences ltd. Investors in myovant sciences ltd.
Get the latest myovant sciences ltd. This chart shows the closing price for myov for the last year in relation to the current analyst high, average, and low pricetarget. Myov need to pay close attention to the stock based on moves in the options market lately.
6 brokers have issued 1 year price objectives for myovant sciences' stock. Zacks zacks is the leading investment research firm focusing on stock research, analysis and recommendations. (nyse:myov) will post ($0.42) earnings per share (eps) for the current quarter, zacks reports.
Zacks 3 big drugmakers likely to be in focus in second half of 2021 eli lilly (lly), pfizer (pfe) and bayer (bayry) are three large drug sector companies worth buying and holding for the next few months and beyond. According to the issued ratings of 6 analysts in the last year, the consensus rating for myovant sciences stock is buy based on the current 3 hold ratings and 3 buy ratings for myov. In fact, the stock has plunged 21% so far this year compared with the industry’s decrease of 0.6%.
That is because the 16 oct, 2020 $25.00 call had some of the highest. Their forecasts range from $18.00 to $32.00. Is dermtech inc stock undervalued?
Shares of myovant were down 6.8% on wednesday despite the positive announcement. Please note that relugolix combination therapy is currently under review in the united states for the treatment of uterine fibroids in women. Myov investment & stock information.
Myov forecast based on data. Et on zacks.com here's why pfizer (pfe) has been rallying this year so far Dermtech inc has risen higher in 3 of those 4 years over the subsequent 52 week period, corresponding to a historical accuracy of 75 % ;
Thu, may 27, 5:40 am, zacks here's why pfizer (pfe) has been rallying this year so far pfizer's. The average price target represents a 16.12% upside from the last price of $22.39. Over the next 52 weeks, dermtech inc has on average historically risen by 70.1 % based on the past 4 years of stock performance.;
This suggests a possible upside of 4.4% from the stock's current price. Myovant sciences posted earnings of ($0.75) per share during […] Do the numbers hold clues to what lies ahead for the stock?
Two analysts have provided estimates for myovant sciences’ earnings, with the highest eps estimate coming in at ($0.32) and the lowest estimate coming in at ($0.58). In 1978, our founder discovered the power of earnings estimate revisions to enable. 2, 2021 at 11:17 a.m.
The current dermtech inc [] share price is $37.50. Over the last 60 days, the net effect has narrowed our zacks consensus estimate for the current quarter from a loss of 71 cents per share to a loss of 67 cents in that period.
Pin von Zack Viola auf firearms Star wars charaktere
Professional wrestler John Cena punches above his weight
PFC (Power Finance Corporation Limited) BUY ABOVE 98.5
Tags: forecast, myov, stock, zacks